期刊文献+

肝移植后神经精神并发症:免疫抑制和丙型肝炎的影响 被引量:2

Neuropsychiatric complications after liver transplantation:Role of immunosuppression and hepatitis C
下载PDF
导出
摘要 Neuropsychiatric complications are an important source of morbidity following orthotopic liver transplantation.Etiology of liver disease and type of immunosuppression are possible related factors.The aim of this study was to describe the prevalence of neuropsychiatric complications after liver transplantation,the role of immunosuppression,and the association between these and specific liver diseases such as hepatitis C.One hundred twenty-eight patients with liver transplants were studied.Tacrolimus was the primary immunosuppressant in 101 patients and cyclosporine in 27 patients.Seventy-five complications in 49 patients(38.2%) were reported.In 43 patients,the etiology was associated with immunosuppression:36 on tacrolimus and 7 on cyclosporine(P = 0.34) .Seventeen and four-tenths percent of patients with hepatitis C and 4.6% of patients without hepatitis C developed depression(P = 0.02) .There is no difference between types of primary immunosuppression and neuropsychiatric complications.There is a significantly greater incidence of depression in patients transplanted for hepatitis C. Neuropsychiatric complications are an important source of morbidity following orthotopic liver transplantation.Etiology of liver disease and type of immunosuppression are possible related factors.The aim of this study was to describe the prevalence of neuropsychiatric complications after liver transplantation,the role of immunosuppression,and the association between these and specific liver diseases such as hepatitis C.One hundred twenty-eight patients with liver transplants were studied.Tacrolimus was the primary immunosuppressant in 101 patients and cyclosporine in 27 patients.Seventy-five complications in 49 patients(38.2%) were reported.In 43 patients,the etiology was associated with immunosuppression:36 on tacrolimus and 7 on cyclosporine(P = 0.34) .Seventeen and four-tenths percent of patients with hepatitis C and 4.6% of patients without hepatitis C developed depression(P = 0.02) .There is no difference between types of primary immunosuppression and neuropsychiatric complications.There is a significantly greater incidence of depression in patients transplanted for hepatitis C.
出处 《世界核心医学期刊文摘(胃肠病学分册)》 2006年第12期9-10,共2页 Core Journals in Gastroenterology
  • 相关文献

同被引文献8

  • 1傅海龙,傅宏,傅志仁,丁国善,张建军,马钧,陈小松,王正昕,倪之嘉.原位肝移植术后发生脑病的相关因素分析[J].中华器官移植杂志,2005,26(6):335-338. 被引量:8
  • 2易述红,许赤,陆敏强,蔡常洁,杨扬,李华,易慧敏,汪根树,赵辉,李敏如,陈规划.原位肝移植术后弥漫性脑病的临床研究[J].中华神经医学杂志,2006,5(9):928-930. 被引量:3
  • 3Bronster DJ,Emre S,Boccagni P,et al.Central nervous system complications in liver transplant recipients-incidence,timing,and long-term follow-up[J].ClinTransplant,2000,14(1):1 -7.
  • 4Dawson TM.Immunosuppressants,immunophilins and the nervous system[J].Ann Neuro1,1996,40(4):559 -560.
  • 5Chabolla DR,Harnois DM,Meschia JF.Levetiracetam monotherapy for liver transplant patients with seizures[j].Transplant Proc,2003,35(4):1480-1481.
  • 6Claudio R. Tombazzi MD,Bradford Waters MD,M. Hosein Shokouh-Amiri MD,Santiago R. Vera MD,Caroline A. Riely MD. Neuropsychiatric Complications After Liver Transplantation: Role of Immunosuppression and Hepatitis C[J] 2006,Digestive Diseases and Sciences(6):1079~1081
  • 7Dr.med. F. Saner DEAA,Y. Gu MD,S. Minouchehr MD,K. Ilker MD,N. R. Fruhauf MD,A. Paul MD,A. Radtke MD,M. Dammann MD,Z. Katsarava MD,S. Koeppen MD,M. Malagó MD,Ch. E. Broelsch MD. Neurological complications after cadaveric and living donor liver transplantation[J] 2006,Journal of Neurology(5):612~617
  • 8Andrea Stracciari,Maria Guarino. Neuropsychiatric Complications of Liver Transplantation[J] 2001,Metabolic Brain Disease(1-2):3~11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部